Neurogene NGNE
NASDAQ NGNE
$25.65 -0.90 (-3.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neurogene (NGNE) Gains from Sales and Divestitures (2013 - 2023)

Updated

Neurogene's Gains from Sales and Divestitures was $200,000 in Q2 2023.

Analysis

Neurogene (NGNE) Gains from Sales and Divestitures (2013 - 2023) Analysis & Trends

On a trailing twelve-month basis, Neurogene's Gains from Sales and Divestitures was -$108,000 through Jun 30, 2023; for FY2022, it was -$118,000.

  • In earlier years, Gains from Sales and Divestitures was -$180,000 in FY2020 and -$5,000 in FY2019.
  • The Q2 2023 figure marks the highest quarterly Gains from Sales and Divestitures in data going back to Q1 2013.
  • Per Business Quant data, NGNE's Gains from Sales and Divestitures in the three quarters before Q2 2023 was -$190,000 (Q1 2023), -$10,000 (Q4 2022) and -$108,000 (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Neurogene 578.46 Mn 578.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 200,000.00
Mar 31, 2023 -190,000.00
Dec 31, 2022 -10,000.00
Sep 30, 2022 -108,000.00
Dec 31, 2020 20,000.00
Sep 30, 2020 -27,000.00
Jun 30, 2020 -200,000.00
Dec 31, 2014 9,360.00
Dec 31, 2013 10,200.00
Sep 30, 2013 26,455.00
Jun 30, 2013 68,502.00
Mar 31, 2013 29,396.00
API Access

Neurogene Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NGNE&period=max&api_key=YOUR_API_KEY